x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DPP-001294
| Product Overview | |
|---|---|
| Species | Human |
| Expression System | Baculovirus infected Sf9 cells |
| Format | Liquid |
| Purity | ≥97% by SDS-PAGE |
| Nature | Recombinant |
| Target Information | |
|---|---|
| Gene Name | SESN1 |
| UniProt No. | Q9Y6P5 |
| Gene ID | 27244 |
| Molecular Weight | 65 kDa including tags |
| Alternative Names | 1110002G11Rik; AU044290; MGC118148; MGC138241; MGC142129; OTTMUSP00000022799; p53 activated gene 26; p53 regulated PA26 nuclear protein; p53 regulated protein PA26; p53-regulated protein PA26; PA26; RP11-787I22.1; sesn1; SESN1_HUMAN; SEST1; sestrin 1; Sestrin-1 |
| Function | Involved in the reduction of peroxiredoxins. May also be regulator of cellular growth. |
| Cellular Localization | Nucleus. |
| Protein Length | Full length protein |
| Sequence | AEGENEVRWDGLCSRDSTTRETALENIRQTILRKTEYLRSVKETPHRPSD GLSNTESSDGLNKLLAHLLMLSKRCPFKDVREKSEFILKSIQELGIRIPR PLGQGPSRFIPEKEILQVGSEDAQMHALFADSFAALGRLDNITLVMVFHP QYLESFLKTQHYLLQMDGPLPLHYRHYIGIMAAARHQCSYLVNLHVNDFL HVGGDPKWLNGLENAPQKLQNLGELNKVLAHRPWLITKEHIEGLLKAEEH SWSLAELVHAVVLLTHYHSLASFTFGCGISPEIHCDGGHTFRPPSVSNYC ICDITNGNHSVDEMPVNSAENVSVSDSFFEVEALMEKMRQLQECRDEEEA SQEEMASRFEIEKRESMFVFSSDDEEVTPARAVSRHFEDTSYGYKDFSRH GMHVPTFRVQDYCWEDHGYSLVNRLYPDVGQLIDEKFHIAYNLTYNTMAM HKDVDTSMLRRAIWNYIHCMFGIRYDDYDYGEINQLLDRSFKVYIKTVVC TPEKVTKRMYDSFWRQFKHSEKVHVNLLLIEARMQAELLYALRAITRYMT,Belongs to the sestrin family. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped on dry ice. |
| Storage | Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
